Enabling single-site laparoscopy: the SPORT platform
- PMID: 30623255
- PMCID: PMC6795913
- DOI: 10.1007/s00464-018-06658-x
Enabling single-site laparoscopy: the SPORT platform
Abstract
Background: The Single Port Orifice Robotic Technology (SPORT) Surgical System by Titan Medical Inc. is designed to overcome the inherent challenges of minimally invasive single-access procedures. The aim of this preclinical study was to evaluate the feasibility of various digestive surgery procedures using this novel surgical robotic platform.
Methods: A total of 12 minimally invasive procedures were performed on six pigs (5 cholecystectomies, 3 Nissen fundoplications, 1 splenectomy and 1 hepatic pedicle dissection) and on one human cadaver (1 cholecystectomy and 1 Nissen fundoplication), by four laparoscopic surgeons. The usability of the device was assessed by means of the modified objective structured assessment of technical skills (OSATS) score that was calculated and analyzed by two independent observers on the recorded videos. Surgeon feedback and recommendations were systematically recorded.
Results: All procedures were successfully completed with the SPORT system. In general, surgeons reported to appreciate the intuitive interface and controls, the high-resolution 3D imaging, the dexterity of the end-effectors, and the ergonomic open control platform. Some features requiring optimization were also identified. The modified OSATS score demonstrated a learning curve effect for all device-related tasks.
Conclusions: A variety of abdominal procedures could be safely completed with the current SPORT prototype, in the preclinical setting. This preliminary feasibility experience is promising and encourages further development of single-port robotically assisted surgery.
Keywords: Laparoscopy; Robotic surgery; SPORT™ Surgical System; Single access; Single-port surgery; Single-site.
Conflict of interest statement
Barbara Seeliger received a travel grant to the 2018 SAGES meeting funded by Titan Medical Inc. Jelle P. Ruurda and Konstantinos M. Konstantinidis received remuneration by Titan Medical Inc. for their participation in this study, and they are proctors for Intuitive Surgical. Jacques Marescaux is the President of both IRCAD and IHU-Strasbourg Institutes, which are partly funded by Karl Storz, Medtronic and Siemens Healthcare. Lee Swanström is Scientific Director and Chief Innovation Officer of the IHU-Strasbourg and is a medical consultant for Titan Medical, Boston Scientific, Olympus, and Apollo Endosurgery. Michele Diana has no conflicts of interest or financial ties to disclose.
Figures




References
-
- Ross S, Rosemurgy A, Albrink M, Choung E, Dapri G, Gallagher S, Hernandez J, Horgan S, Kelley W, Kia M, Marks J, Martinez J, Mintz Y, Oleynikov D, Pryor A, Rattner D, Rivas H, Roberts K, Rubach E, Schwaitzberg S, Swanstrom L, Sweeney J, Wilson E, Zemon H, Zundel N. Consensus statement of the consortium for LESS cholecystectomy. Surg Endosc. 2012;26:2711–2716. doi: 10.1007/s00464-012-2478-y. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical